rcca-header
Clinical Trials

A Randomized, Double-Blind Phase 3 Study of Ibrutinib in Combination With Corticosteroids versus Placebo in Combination With Corticosteroids in Subjects with New Onset Chronic Graft Versus Host Disease (cGVHD)

Type of Cancer
Phase
Division (Location)
Hackensack, NJ
Study ID
NCT#
Brief Description
A Randomized, Double-Blind Phase 3 Study of Ibrutinib in Combination With Corticosteroids versus Placebo in Combination With Corticosteroids in Subjects with New Onset Chronic Graft Versus Host Disease (cGVHD)

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.